Pregnancy Incidence and Outcomes Among Women Receiving Preexposure Prophylaxis for HIV Prevention: A Randomized Clinical Trial.

Publication Type:

Journal Article

Source:

JAMA : the journal of the American Medical Association, Volume 312, Issue 4, p.362-71 (2014)

Keywords:

2014, August 2014, Vaccine and Infectious Disease Division

Abstract:

Antiretroviral preexposure prophylaxis (PrEP), using tenofovir disoproxil fumarate (TDF) and combination emtricitabine/tenofovir disoproxil fumarate (FTC+TDF), is efficacious for prevention of human immunodeficiency virus (HIV) acquisition. PrEP could reduce periconception HIV risk, but the effect on pregnancy outcomes is not well defined.